GSA Capital Partners LLP Purchases Shares of 22,274 Azenta, Inc. $AZTA

GSA Capital Partners LLP purchased a new position in Azenta, Inc. (NASDAQ:AZTAFree Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 22,274 shares of the company’s stock, valued at approximately $568,000.

A number of other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Azenta by 2.2% during the fourth quarter. Vanguard Group Inc. now owns 4,538,946 shares of the company’s stock valued at $150,965,000 after acquiring an additional 99,588 shares during the last quarter. Conestoga Capital Advisors LLC grew its stake in shares of Azenta by 116.1% in the first quarter. Conestoga Capital Advisors LLC now owns 2,844,546 shares of the company’s stock worth $60,105,000 after purchasing an additional 1,528,145 shares during the last quarter. Millennium Management LLC increased its holdings in Azenta by 9.9% during the 4th quarter. Millennium Management LLC now owns 1,866,531 shares of the company’s stock valued at $62,081,000 after purchasing an additional 167,969 shares during the period. State Street Corp increased its holdings in Azenta by 1.4% during the 4th quarter. State Street Corp now owns 1,732,755 shares of the company’s stock valued at $57,631,000 after purchasing an additional 24,062 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its position in Azenta by 16.3% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,613,914 shares of the company’s stock valued at $34,183,000 after purchasing an additional 225,867 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on AZTA shares. Needham & Company LLC increased their price objective on Azenta from $33.00 to $37.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Weiss Ratings cut Azenta from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, August 11th. Four analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $41.20.

View Our Latest Analysis on AZTA

Azenta Trading Up 2.5%

Shares of AZTA opened at $36.51 on Friday. Azenta, Inc. has a 1-year low of $15.93 and a 1-year high of $41.73. The firm’s 50-day moving average price is $27.62 and its 200-day moving average price is $25.06. The firm has a market capitalization of $1.60 billion, a price-to-earnings ratio of -13.23 and a beta of 1.37.

Azenta (NASDAQ:AZTAGet Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%. The company had revenue of $161.18 million during the quarter, compared to the consensus estimate of $149.31 million.

Azenta Profile

(Free Report)

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.

Read More

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.